类风湿性关节炎
医学
磺胺吡啶
羟基氯喹
甲氨蝶呤
免疫系统
关节炎
免疫学
内科学
疾病
2019年冠状病毒病(COVID-19)
溃疡性结肠炎
传染病(医学专业)
作者
Sudha Vengurlekar,S. Chaturvedi
出处
期刊:BENTHAM SCIENCE PUBLISHERS eBooks
[Bentham Science Publishers]
日期:2022-08-19
卷期号:: 72-96
标识
DOI:10.2174/9789815050776122010006
摘要
Rheumatoid arthritis is a severe systemic autoimmune disorder with limited option available for treatment and no curative therapy available at present. Rheumatoid arthritis manifests clinically through polyarthralgia related to joint dysfunction, which triggers the autoimmune responses associated with antibodies against the self.neoepitopes and causes the chronic arthritic attack. Bone destruction is an important feature to understand the pathology of rheumatoid arthritis, which may lead to a serious concern for the patient for living a quality life. Available drugs for rheumatoid arthritis such as methotrexate, hydroxychloroquine, and sulfasalazine exert effects on bone metabolism in immune cells and cytokines that result in relieving pain, improving the quality of life but still, the chronic teratogenic and toxic effects are challenging in management of anti-arthritic drugs. This chapter reviews the current trend of bioactive compounds for the treatment of rheumatoid arthritis, which may lead to the development of novel anti-rheumatoid arthritis agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI